Emphasizing risk to the newborn is viewed as an effective strategy for overcoming maternal vaccine reluctance.
Routine immunization of pregnant women against pertussis and influenza is recommended, yet coverage in the U.S remains suboptimal. In a nationally representative survey of 331 obstetrician-gynecologists (ob-gyns; 69% response rate), investigators explored the beliefs that lead women to refuse these immunizations and the clinical strategies perceived as best for overcoming vaccine hesitance.
Vaccine refusal by >10% of pregnant patients was noted by 62% of ob-gyns for influenza vaccine and 32% of ob-gyns for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Physicians reported that their patients refused vaccines because these women believed the influenza vaccine made them ill (48%), they felt they were not at risk for…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)